These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 16030196)

  • 1. Overexpression of Shp2 tyrosine phosphatase is implicated in leukemogenesis in adult human leukemia.
    Xu R; Yu Y; Zheng S; Zhao X; Dong Q; He Z; Liang Y; Lu Q; Fang Y; Gan X; Xu X; Zhang S; Dong Q; Zhang X; Feng GS
    Blood; 2005 Nov; 106(9):3142-9. PubMed ID: 16030196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of SHP2 protein-tyrosine phosphatase increases HoxA10-induced repression of the genes encoding gp91(PHOX) and p67(PHOX).
    Lindsey S; Huang W; Wang H; Horvath E; Zhu C; Eklund EA
    J Biol Chem; 2007 Jan; 282(4):2237-49. PubMed ID: 17138561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activating mutations of the noonan syndrome-associated SHP2/PTPN11 gene in human solid tumors and adult acute myelogenous leukemia.
    Bentires-Alj M; Paez JG; David FS; Keilhack H; Halmos B; Naoki K; Maris JM; Richardson A; Bardelli A; Sugarbaker DJ; Richards WG; Du J; Girard L; Minna JD; Loh ML; Fisher DE; Velculescu VE; Vogelstein B; Meyerson M; Sellers WR; Neel BG
    Cancer Res; 2004 Dec; 64(24):8816-20. PubMed ID: 15604238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leukemia-associated, constitutively active mutants of SHP2 protein tyrosine phosphatase inhibit NF1 transcriptional activation by the interferon consensus sequence binding protein.
    Huang W; Saberwal G; Horvath E; Zhu C; Lindsey S; Eklund EA
    Mol Cell Biol; 2006 Sep; 26(17):6311-32. PubMed ID: 16914719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The tyrosine phosphatase Shp2 interacts with NPM-ALK and regulates anaplastic lymphoma cell growth and migration.
    Voena C; Conte C; Ambrogio C; Boeri Erba E; Boccalatte F; Mohammed S; Jensen ON; Palestro G; Inghirami G; Chiarle R
    Cancer Res; 2007 May; 67(9):4278-86. PubMed ID: 17483340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Shp2 function in hematopoietic stem cell biology and leukemogenesis.
    Nabinger SC; Chan RJ
    Curr Opin Hematol; 2012 Jul; 19(4):273-9. PubMed ID: 22504523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of alpha-catenin Tyr phosphorylation by SHP2 positively effects cell transformation induced by the constitutively active FGFR3.
    Burks J; Agazie YM
    Oncogene; 2006 Nov; 25(54):7166-79. PubMed ID: 16767162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of SHP2 in hematopoiesis and leukemogenesis.
    Pandey R; Saxena M; Kapur R
    Curr Opin Hematol; 2017 Jul; 24(4):307-313. PubMed ID: 28306669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Shp2, a novel oncogenic tyrosine phosphatase and potential therapeutic target for human leukemia.
    Xu R
    Cell Res; 2007 Apr; 17(4):295-7. PubMed ID: 17404595
    [No Abstract]   [Full Text] [Related]  

  • 10. The role of Shp2 (PTPN11) in cancer.
    Mohi MG; Neel BG
    Curr Opin Genet Dev; 2007 Feb; 17(1):23-30. PubMed ID: 17227708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutated Ptpn11 alters leukemic stem cell frequency and reduces the sensitivity of acute myeloid leukemia cells to Mcl1 inhibition.
    Chen L; Chen W; Mysliwski M; Serio J; Ropa J; Abulwerdi FA; Chan RJ; Patel JP; Tallman MS; Paietta E; Melnick A; Levine RL; Abdel-Wahab O; Nikolovska-Coleska Z; Muntean AG
    Leukemia; 2015 Jun; 29(6):1290-300. PubMed ID: 25650089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Noonan syndrome-associated SHP2/PTPN11 mutants cause EGF-dependent prolonged GAB1 binding and sustained ERK2/MAPK1 activation.
    Fragale A; Tartaglia M; Wu J; Gelb BD
    Hum Mutat; 2004 Mar; 23(3):267-77. PubMed ID: 14974085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic, therapeutic, and mechanistic implications of a mouse model of leukemia evoked by Shp2 (PTPN11) mutations.
    Mohi MG; Williams IR; Dearolf CR; Chan G; Kutok JL; Cohen S; Morgan K; Boulton C; Shigematsu H; Keilhack H; Akashi K; Gilliland DG; Neel BG
    Cancer Cell; 2005 Feb; 7(2):179-91. PubMed ID: 15710330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ANKHD1, ankyrin repeat and KH domain containing 1, is overexpressed in acute leukemias and is associated with SHP2 in K562 cells.
    Traina F; Favaro PM; Medina Sde S; Duarte Ada S; Winnischofer SM; Costa FF; Saad ST
    Biochim Biophys Acta; 2006 Sep; 1762(9):828-34. PubMed ID: 16956752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eya2, a Target Activated by Plzf, Is Critical for
    Ono R; Masuya M; Ishii S; Katayama N; Nosaka T
    Mol Cell Biol; 2017 Jul; 37(13):. PubMed ID: 28416638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Constitutively active SHP2 cooperates with HoxA10 overexpression to induce acute myeloid leukemia.
    Wang H; Lindsey S; Konieczna I; Bei L; Horvath E; Huang W; Saberwal G; Eklund EA
    J Biol Chem; 2009 Jan; 284(4):2549-67. PubMed ID: 19022774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutation of Thr466 in SHP2 abolishes its phosphatase activity, but provides a new substrate-trapping mutant.
    Merritt R; Hayman MJ; Agazie YM
    Biochim Biophys Acta; 2006 Jan; 1763(1):45-56. PubMed ID: 16413071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Noonan syndrome mutation Q79R in Shp2 increases proliferation of valve primordia mesenchymal cells via extracellular signal-regulated kinase 1/2 signaling.
    Krenz M; Yutzey KE; Robbins J
    Circ Res; 2005 Oct; 97(8):813-20. PubMed ID: 16166557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuronal Shp2 tyrosine phosphatase controls energy balance and metabolism.
    Zhang EE; Chapeau E; Hagihara K; Feng GS
    Proc Natl Acad Sci U S A; 2004 Nov; 101(45):16064-9. PubMed ID: 15520383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [SHP2 and MKP5 in P2Y purinergic receptor-mediated prostate cancer invasion].
    He HY; Zheng J; Li Y; Heng WJ; Fang WG
    Zhonghua Bing Li Xue Za Zhi; 2005 May; 34(5):288-92. PubMed ID: 16181551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.